Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Interventions: Drug: Rituximab Sponsors: Istituto Clinico Humanitas; IRCCS National Neurological Institute " C. Mondino " Foundation Completed

https://clinicaltrials.gov/study/NCT06325943

Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

More News: Brain | CIDP | Neurology | Research | Rituxan